Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1928–1934. doi: 10.1111/j.1476-5381.1991.tb12354.x

Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.

D F Schoors 1, G P Vauquelin 1, H De Vos 1, G Smets 1, B Velkeniers 1, L Vanhaelst 1, A G Dupont 1
PMCID: PMC1908193  PMID: 1833020

Abstract

1. We studied the lactotroph cells of the rat by both in vivo and in vitro pharmacological techniques for the presence of D1-receptors. Both approaches revealed the presence of D2-receptor, stimulated by quinpirole (resulting in an inhibition of prolactin secretion) and blocked by domperidone. 2. Administration of fenoldopam, the most selective D1-receptor agonist currently available, resulted in a dose-dependent decrease of prolactin secretion in vivo (after pretreatment with alpha-methyl-p-tyrosine) and in vitro (cultured pituitary cells). This increase was dose-dependently blocked by the selective D1-receptor antagonist, SCH 23390, and although the effect of fenoldopam was less than that obtained by D2-receptor stimulation, these data suggest that a D1-receptor also controls prolactin secretion. 3. In order to detect the location of these dopamine receptors, autoradiographic studies were performed by use of [3H]-SCH 23390 and [3H]-spiperone as markers for D1- and D2-receptors, respectively. Specific binding sites for [3H]-SCH 23390 were demonstrated. Fenoldopam dose-dependently reduced [3H]-SCH 23390 binding, but had no effect on [3H]-spiperone binding. Immunocytochemical labelling of prolactin cells after incubation with [3H]-SCH 23390 revealed that the granulae and hence, D1 binding sites were present on the lactotroph cells. 4. Radioligand binding studies performed on membranes from anterior pituitary cells revealed the presence of the D2-receptor (54 fmol mg-1 protein) with a Kd of 0.58 nM for [3H]-spiperone, but failed to detect D1-receptors. 5. Finally, we studied the effect of dopamine and of fenoldopam on the adenosine 3':5'-cyclic monophosphate (cyclic AMP) content of anterior pituitary cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1928

Images in this article

1931Figure 4
on p.1931
1932Figure 5
on p.1932

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen P. H., Gingrich J. A., Bates M. D., Dearry A., Falardeau P., Senogles S. E., Caron M. G. Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci. 1990 Jun;11(6):231–236. doi: 10.1016/0165-6147(90)90249-8. [DOI] [PubMed] [Google Scholar]
  2. Apud J. A., Masotto C., Ongini E., Racagni G. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat. Eur J Pharmacol. 1985 Jun 7;112(2):187–193. doi: 10.1016/0014-2999(85)90495-9. [DOI] [PubMed] [Google Scholar]
  3. Berridge M. J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159–193. doi: 10.1146/annurev.bi.56.070187.001111. [DOI] [PubMed] [Google Scholar]
  4. Boesgaard S., Hagen C., Andersen A. N., Eldrup E., Lange P. Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion. Clin Endocrinol (Oxf) 1989 Mar;30(3):231–239. doi: 10.1111/j.1365-2265.1989.tb02231.x. [DOI] [PubMed] [Google Scholar]
  5. Buydens P., Govaerts J., Velkeniers B., Finné E., Vanhaelst L. The effect of bombesin on basal, alpha-methyl-p-tyrosine, haloperidol, morphine, bremazocine and stress-induced prolactin secretion. Life Sci. 1988;43(21):1755–1760. doi: 10.1016/0024-3205(88)90488-2. [DOI] [PubMed] [Google Scholar]
  6. Caron M. G., Beaulieu M., Raymond V., Gagné B., Drouin J., Lefkowitz R. J., Labrie F. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem. 1978 Apr 10;253(7):2244–2253. [PubMed] [Google Scholar]
  7. Cocchi D., Ingrassia S., Rusconi L., Villa I., Müller E. E. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary. Eur J Pharmacol. 1987 Oct 27;142(3):425–429. doi: 10.1016/0014-2999(87)90082-3. [DOI] [PubMed] [Google Scholar]
  8. Creese I., Sibley D. R., Hamblin M. W., Leff S. E. The classification of dopamine receptors: relationship to radioligand binding. Annu Rev Neurosci. 1983;6:43–71. doi: 10.1146/annurev.ne.06.030183.000355. [DOI] [PubMed] [Google Scholar]
  9. De Keyser J., Claeys A., De Backer J. P., Ebinger G., Roels F., Vauquelin G. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett. 1988 Aug 31;91(2):142–147. doi: 10.1016/0304-3940(88)90758-6. [DOI] [PubMed] [Google Scholar]
  10. De Keyser J., Dierckx R., Vanderheyden P., Ebinger G., Vauquelin G. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res. 1988 Mar 8;443(1-2):77–84. doi: 10.1016/0006-8993(88)91600-9. [DOI] [PubMed] [Google Scholar]
  11. Del Pozo E., Del Re R. B., Varga L., Friesen H. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). J Clin Endocrinol Metab. 1972 Nov;35(5):768–771. doi: 10.1210/jcem-35-5-768. [DOI] [PubMed] [Google Scholar]
  12. Denef C. Paracrine interactions in the anterior pituitary. Clin Endocrinol Metab. 1986 Feb;15(1):1–32. doi: 10.1016/s0300-595x(86)80040-8. [DOI] [PubMed] [Google Scholar]
  13. Dumbrille-Ross A., Seeman P. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary. Biochem Pharmacol. 1987 Jul 1;36(13):2095–2099. doi: 10.1016/0006-2952(87)90136-5. [DOI] [PubMed] [Google Scholar]
  14. Dupont A. G., Lefebvre R. A., Vanderniepen P. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed. Br J Pharmacol. 1987 Jul;91(3):493–501. doi: 10.1111/j.1476-5381.1987.tb11242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dupont A. G., Vanderniepen P., Volckaert A., Smitz J., Vansteirteghem A. C., Six R. O. Effect of fenoldopam on the aldosterone response to metoclopramide in man. Clin Endocrinol (Oxf) 1986 Feb;24(2):203–208. doi: 10.1111/j.1365-2265.1986.tb00763.x. [DOI] [PubMed] [Google Scholar]
  16. Enjalbert A., Bockaert J. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol. 1983 May;23(3):576–584. [PubMed] [Google Scholar]
  17. Enjalbert A., Sladeczek F., Guillon G., Bertrand P., Shu C., Epelbaum J., Garcia-Sainz A., Jard S., Lombard C., Kordon C. Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem. 1986 Mar 25;261(9):4071–4075. [PubMed] [Google Scholar]
  18. Felder C. C., Jose P. A., Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther. 1989 Jan;248(1):171–175. [PubMed] [Google Scholar]
  19. Foord S. M., Peters J. R., Dieguez C., Scanlon M. F., Hall R. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology. 1983 May;112(5):1567–1577. doi: 10.1210/endo-112-5-1567. [DOI] [PubMed] [Google Scholar]
  20. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gunnet J. W., Moore K. E. Neuroleptics and neuroendocrine function. Annu Rev Pharmacol Toxicol. 1988;28:347–366. doi: 10.1146/annurev.pa.28.040188.002023. [DOI] [PubMed] [Google Scholar]
  22. Hahn R. A., Wardell J. R., Jr, Sarau H. M., Ridley P. T. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther. 1982 Nov;223(2):305–313. [PubMed] [Google Scholar]
  23. Hsu S. M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981 May;75(5):734–738. doi: 10.1093/ajcp/75.5.734. [DOI] [PubMed] [Google Scholar]
  24. Hyttel J. SCH 23390 - the first selective dopamine D-1 antagonist. Eur J Pharmacol. 1983 Jul 15;91(1):153–154. doi: 10.1016/0014-2999(83)90381-3. [DOI] [PubMed] [Google Scholar]
  25. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  27. Mailman R. B., Schulz D. W., Kilts C. D., Lewis M. H., Rollema H., Wyrick S. The multiplicity of the D1 dopamine receptor. Adv Exp Med Biol. 1986;204:53–72. doi: 10.1007/978-1-4684-5191-7_4. [DOI] [PubMed] [Google Scholar]
  28. Nikitovitch-Winer M. B., Atkin J., Maley B. E. Colocalization of prolactin and growth hormone within specific adenohypophyseal cells in male, female, and lactating female rats. Endocrinology. 1987 Aug;121(2):625–630. doi: 10.1210/endo-121-2-625. [DOI] [PubMed] [Google Scholar]
  29. Peroutka S. J. 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci. 1988;11:45–60. doi: 10.1146/annurev.ne.11.030188.000401. [DOI] [PubMed] [Google Scholar]
  30. Rovescalli A. C., Brunello N., Monopoli A., Ongini E., Racagni G. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion. Eur J Pharmacol. 1987 Mar 17;135(2):129–136. doi: 10.1016/0014-2999(87)90604-2. [DOI] [PubMed] [Google Scholar]
  31. Sabouni M. H., Alkadhi K. A., Lokhandwala M. F. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog. J Pharmacol Exp Ther. 1987 Jan;240(1):93–98. [PubMed] [Google Scholar]
  32. Saller C. F., Salama A. I. D-1 dopamine receptor stimulation elevates plasma prolactin levels. Eur J Pharmacol. 1986 Mar 11;122(1):139–142. doi: 10.1016/0014-2999(86)90170-6. [DOI] [PubMed] [Google Scholar]
  33. Sibley D. R., De Lean A., Creese I. Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. J Biol Chem. 1982 Jun 10;257(11):6351–6361. [PubMed] [Google Scholar]
  34. Stoof J. C., Kebabian J. W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981 Nov 26;294(5839):366–368. doi: 10.1038/294366a0. [DOI] [PubMed] [Google Scholar]
  35. Stoof J. C., Kebabian J. W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984 Dec 3;35(23):2281–2296. doi: 10.1016/0024-3205(84)90519-8. [DOI] [PubMed] [Google Scholar]
  36. Swennen L., Denef C. Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release. Endocrinology. 1982 Aug;111(2):398–405. doi: 10.1210/endo-111-2-398. [DOI] [PubMed] [Google Scholar]
  37. Van der Niepen P., Dupont A. G., Finne E., Six R. O. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat. J Hypertens Suppl. 1988 Dec;6(4):S687–S689. doi: 10.1097/00004872-198812040-00216. [DOI] [PubMed] [Google Scholar]
  38. Velkeniers B., Hooghe-Peters E. L., Hooghe R., Belayew A., Smets G., Claeys A., Robberecht P., Vanhaelst L. Prolactin cell subpopulations separated on discontinuous Percoll gradient: an immunocytochemical, biochemical, and physiological characterization. Endocrinology. 1988 Sep;123(3):1619–1630. doi: 10.1210/endo-123-3-1619. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES